Jane Street’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Jane Street’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,200	Closed	-$2.09M	–	9752
2023 Q2	$2.09M	Sell	53,200 -115,400	-68%	-$4.07M	﹤0.01%	4102
2023 Q1	$4.1M	Buy	168,600 +55,100	+49%	+$1.21M	﹤0.01%	2718
2022 Q4	$2.43M	Sell	113,500 -157,200	-58%	-$3.36M	﹤0.01%	3555
2022 Q3	$4.86M	Buy	270,700 +204,300	+308%	+$2.68M	﹤0.01%	2670
2022 Q2	$639K	Buy	+66,400	New	+$833K	﹤0.01%	6305
2021 Q4	–	Sell	-178,900	Closed	-$2.9M	–	11044
2021 Q3	$2.9M	Buy	+178,900	New	+$1.95M	﹤0.01%	3726
2017 Q1	–	Sell	-17,100	Closed	-$83K	–	4828
2016 Q4	$83K	Buy	+17,100	New	+$508K	﹤0.01%	3899

Jane Street's ISEE Position: Q3 2023 in Review

Jane Street sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 454,619 shares — an estimated $17.9M sold.

Jane Street first reported a position in ISEE in Q2 2014 and held it in 20 quarters. The position peaked at $17.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Jane Street reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 454,619 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $17.9M.
Jane Street first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 20 quarters.
Jane Street's IVERIC bio, Inc. Common Stock position peaked at $17.9M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.